Formulations for preventing mosquito bites

Patent metadata

Field	Value
Publication number	US-2025345261-A1
Application number	US-202319130562-A
Country	US
Kind code	A1
Filing date	Nov 15, 2023
Priority date	Nov 17, 2022
Publication date	Nov 13, 2025
Grant date	—

Abstract

The invention contemplates methods and formulations for reducing biting by insects.

First claim

1 .- 40 . (canceled)

41 . A formulation for direct application onto a skin region of a subject for reducing or preventing insects from biting the skin region and/or for reducing or preventing bite-related skin condition and/or for reducing or preventing transmittal of an insect-borne disease, the formulation comprising a skin-hydrating fluid and cellulose nanocrystals (CNC).

42 . The formulation according to claim 41 , wherein the reducing or preventing is achievable by minimizing, diminishing or preventing skin-semiochemicals emitted from the skin region to sufficiently disperse or spread so as to be detected by the insect.

43 . The formulation according to claim 41 , wherein the reducing or preventing is achievable by minimizing or reducing concentration of skin-semiochemicals emitted from the skin region to below 100 ppm or to below 100 ppb level and/or by reducing external temperature of the skin region having the formulation applied thereon.

44 . The formulation according to claim 41 , wherein the reducing or preventing is by forming a film of the formulation having a thickness of between 10 microns and 1 mm.

45 . The formulation according to claim 41 , wherein the hydrating agent is glycerol, sorbitol, propylene glycol or mixtures thereof.

46 . The formulation according to claim 41 , the formulation being free of an insect repellent.

47 . The formulation according to claim 41 , the formulation comprising indole.

48 . The formulation according to claim 41 , comprising CNC, glycerol and indole.

49 . A formulation for minimizing, diminishing or preventing skin-semiochemicals emitted from the skin region to disperse or spread so as to be detected by a mosquito, the formulation being adapted for direct application onto an exposed skin region of a subject for forming a film of said formulation, thereby reducing or preventing mosquitos from biting the skin region, the formulation comprising glycerol, CNC and optionally indole.

50 . The formulation according to claim 49 , comprising indole.

51 . A method for preventing or reducing insect biting, the method comprises applying an effective amount of a formulation according to claim 41 to an exposed area of a skin of a subject and forming a film or a coat of said formulation on said area of the skin.

52 . The method according to any one of claim 51 , wherein the biting insect is a mosquito.

53 . The method according to claim 51 , for preventing or minimizing or reducing a mosquito-borne disease selected from malaria, dengue, West Nile virus, chikungunya, yellow fever, dirofilariasis, filariasis, tularemia, Japanese encephalitis, Saint Louis encephalitis, Western equine encephalitis, Eastern equine encephalitis, Venezuelan equine encephalitis, Ross River fever, Barmah Forest fever, La Crosse encephalitis, Zika fever.

54 . The method according to claim 51 , wherein the formulation is in a form of a cosmetic formulation, or as a multipurpose formulation.

55 . The method according to claim 51 , wherein the formulation is in a form of a cream, a lotion, an ointment, or a spray.

56 . A kit in a form of a skin applicator comprising a formulation according to claim 41 and instructions of use.

Assignees

• Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd

Inventors

• Shoseyov Oded
• Paltiel Yosef
• Bohbot Jonathan
• Voignac Daniel
• Sar-Shalom Evyatar

Classifications

• A61Q17/02

  containing insect repellants · CPC title

• A61K2800/30

  Characterized by the absence of a particular group of ingredients · CPC title

• A61K8/492

  having condensed rings, e.g. indol · CPC title

• A61K8/345

  containing more than one hydroxy group · CPC title

• A61K8/04

  Dispersions; Emulsions · CPC title